Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Genzyme's
oral Gaucher drug helps strengthen bone 12:04 PM 2/13/2010
Reuters
Genzyme Corp's experimental pill eliglustat tartrate (formerly
GENZ-112638) to treat Gaucher disease was effective strengthening bone, increasing blood count, and decreasing
the size of bloated organs by a significant amount.
...
Health-care
push losing another key player 11:52 AM 2/13/2010
Washington Post
The resignation of influential lobbyist and head of the Pharmaceutical Research
and Manufacturers of America will hurt the White House.
...
Shire
reports positive data on Gaucher drug 1:16 PM 2/11/2010
Forbes
Shire PLC said its potential Gaucher disease drug velaglucerase alfa showed positive
results in a late-stage study.
...
Cadence
says FDA refuses to OK pain drug 1:02 PM 2/11/2010
Reuters
Cadence Pharmaceuticals Inc said the US FDA has declined to approve its experimental
intravenous painkiller because of manufacturing deficiencies.
...
Roche
diabetes drug cuts blood sugar in 5 studies 5:33 AM 2/11/2010
Reuters
Roche licensed taspoglutide from Ipsen for the GLP-1 drug market. The
weekly diabetes drug reduced blood sugar compared with other treatments across five late-stage clinical trials.
...
Scientists
find clue to anxiety drug addiction 4:22 PM 2/10/2010
Reuters
Benzodiazepine drugs like Ativan, Xanax, and Valium exert a calming effect by boosting
action of a gamma-aminobutyric acid (GABA) neurotransmitter in the same way as addictive drugs like opioids and
cannabinoids.
...
Alexza
inks deal with Biovail for anti-psychotic drug 6:51 AM 2/10/2010
Reuters
Alexza Pharmaceuticals Inc signed a collaboration deal with a unit of
Biovail Corp to develop and commercialize its inhaled treatment for agitation AZ-004 in the US and Canada.
...
Amgen
Drug Reduces Bone Breaks in Prostate Patients 8:21 PM 2/8/2010
BusinessWeek
Amgen Inc's denosumab cut the risk of bone fractures better than
Novartis’ Zometa in patients with prostate cancer whose malignancy had spread to their bones.
...
Alzheimer's
drug Dimebon helps Huntington's 5:11 PM 2/8/2010
Reuters
Medivation Inc's Dimebon (latrepirdine) appears to be safe for Huntington's patients
and has minimal side effects. The potential Alzheimer's disease drug helped Huntington's patients improve
thinking, learning, and memory skills.
...
FDA
staff questions Cell Therapeutics drug data 11:24 AM 2/8/2010
Reuters
The US FDA questioned effectiveness data from Cell Therapeutics Inc for
experimental lymphoma drug Pixuvri (pixantrone) saying it carried substantial side effects.
...
Almirall
gets EU approval for prostate drug 5:05 AM 2/8/2010
Reuters
Almirall received European Commission approval to sell silodosin to treat the
enlargement of the prostate gland (BPH).
...
Par
Pharma unit says FDA declines nausea drug approval 3:00 PM 2/5/2010
Reuters
Par Pharmaceutical Cos Inc's Strativa Pharmaceuticals unit said the US FDA
declined to approve its nausea drug Zuplenz. FDA was unable to perform an inspection of the clinical and
analytical sites for a bioequivalence study due to an agency-wide restriction on foreign travel in India.
...
FDA
Finds Drug Official Had No Conflict, Stepped Aside
Voluntarily 5:07 AM 2/5/2010
Baltimore
Sun
US FDA determines that collaboration between top official Janet Woodcock and scientists for
Momenta Pharmaceuticals while the firm had a drug application pending did not constitute a conflict of interest.
Competitor Amphastar Pharmaceuticals Inc disagrees.
...
New
malaria vaccine shows promise in children 5:08 PM 2/3/2010
Reuters
A new vaccine from GlaxoSmithKline targets the malaria parasite as it is
actively infecting red blood cells and causing fever and illness.
...
Vertex
cystic fibrosis drug shows promise in trial 3:03 PM 2/3/2010
Reuters
Vertex Pharmaceuticals Inc said preliminary analysis of data from a 28-day
trial of drug VX-809 showed patients experienced a decline in sweat chloride.
...
<- Day Earlier | Today's News
|
